73 related articles for article (PubMed ID: 2533820)
1. Cell reaction to concanavalin A in cancer patients.
Knejzlíková H; Kolár Z; Kovarík J; Jansa P
Acta Univ Palacki Olomuc Fac Med; 1989; 123():123-30. PubMed ID: 2533820
[TBL] [Abstract][Full Text] [Related]
2. [Suppressor activity induced by concanavalin A in peripheral blood lymphocytes of patients with solid malignant tumors].
García MS; Barañao RI; Fernández O; Rumi LS
Acta Physiol Lat Am; 1983; 33(1):15-20. PubMed ID: 6229133
[TBL] [Abstract][Full Text] [Related]
3. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
[TBL] [Abstract][Full Text] [Related]
4. Cellular reaction to concanavalin A studied by the skin window method in healthy subjects and in patients with malignant tumors.
Kolár Z; Jansa P; Kovarík J; Skovránková H; Krcová I
Acta Univ Palacki Olomuc Fac Med; 1987; 117():73-80. PubMed ID: 2977713
[No Abstract] [Full Text] [Related]
5. [Cellular immunity in breast cancer patients].
Spielmann M; Kitschke HJ; Tietje K
Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
[TBL] [Abstract][Full Text] [Related]
6. The effect of concanavalin-A (Con A) stimulation on lymphocyte subpopulations.
Sanal O; Ersoy F; Yegin O; Berkel AI
Boll Ist Sieroter Milan; 1982 May; 61(2):107-11. PubMed ID: 6982050
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of lymphocyte blastogenesis--inhibiting factors in sera of melanoma patients.
Rangel DM; Golub SH; Morton DL
Surgery; 1977 Aug; 82(2):224-32. PubMed ID: 877866
[TBL] [Abstract][Full Text] [Related]
8. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
9. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
Gupta S; Cunningham-Rundles S
J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte reactivity to mitogens and tumor sex steroid receptors in breast cancer patients.
Kastelan M; Rudolf M; Hrsak M; Stojkovic R; Gamulin S
Biomed Pharmacother; 1985; 39(8):442-4. PubMed ID: 3834952
[TBL] [Abstract][Full Text] [Related]
11. Maximizing differences in the concanavalin A-induced blastogenic responses of lymphocytes from breast cancer patients and controls by the use of alpha-methyl-D-mannoside.
Distasio JA; Cheresh DA; Schilder RJ; Vogel CL; Silverman MA; Lopez DM
J Natl Cancer Inst; 1982 Jan; 68(1):68-9. PubMed ID: 6948127
[TBL] [Abstract][Full Text] [Related]
12. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
Nowak JS; Lanzrein C
Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
[TBL] [Abstract][Full Text] [Related]
13. Characterization of immunoregulatory T lymphocytes during ageing by monoclonal antibodies.
Mascart-Lemone F; Delespesse G; Servais G; Kunstler M
Clin Exp Immunol; 1982 Apr; 48(1):148-54. PubMed ID: 6211314
[TBL] [Abstract][Full Text] [Related]
14. Effect of mitogenic and high, nonmitogenic concentrations of phytohemagglutinin and concanavalin A on the number of human lymphocytes in culture.
Distelhorst CW; Benutto BM
J Reticuloendothel Soc; 1982 Apr; 31(4):307-16. PubMed ID: 6809939
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-induced blastogenesis and receptor mobility inhibition by breast cancer serum with elevated orosomucoid (alpha 1-acid glycoprotein) levels.
Cheresh DA; Distasio JA; Vogel CL; Lopez DM
J Natl Cancer Inst; 1982 May; 68(5):779-83. PubMed ID: 6951088
[TBL] [Abstract][Full Text] [Related]
16. [Cellular immunity indices in benign breast tumors].
Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of suppressor-cell activity by cyclophosphamide in patients with malignant melanoma.
Livingston PO; Cunningham-Rundles S; Marfleet G; Gnecco C; Wong GY; Schiffman G; Enker WE; Hoffman MK
J Biol Response Mod; 1987 Aug; 6(4):392-403. PubMed ID: 2957470
[TBL] [Abstract][Full Text] [Related]
18. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
19. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.
Palacios R
J Immunol; 1982 Jan; 128(1):337-42. PubMed ID: 6459373
[TBL] [Abstract][Full Text] [Related]
20. [Immune reactivity and in vitro effect of levamisole in a group of patients with malignant melanoma].
Sansoni P; Rossetti A; Valente G; Butturini U
Boll Ist Sieroter Milan; 1982 Mar; 61(1):51-7. PubMed ID: 6982048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
